New DNA test could speed up pneumonia diagnosis in ICU patients

NCT ID NCT07626073

ENROLLING_BY_INVITATION Diagnosis Sponsor: China Medical University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new diagnostic tool called RPIP, which uses advanced DNA sequencing to quickly identify the germs causing pneumonia and their drug resistance. The goal is to see if this method helps doctors choose the right treatment faster than current tests. The study will involve 200 ICU patients with pneumonia across multiple hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Respiratory Pathogen ID/AMR Panel (RPIP) – a targeted next-generation sequencing test
What this could lead to: If successful, this could lead to faster, more accurate diagnosis of pneumonia in ICU patients, helping doctors choose the right antibiotics sooner and potentially saving lives.
What could go wrong: This is an early-stage study with only 200 participants, so results may not apply to all patients. The new test may not be more accurate or faster than existing methods in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RESPIRATORY PATHOGENS

Contacts and locations

Locations

Biomedical Technology R&D Center

Taichung, 40447, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.